Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 5;137(17):2052-2064.
doi: 10.1097/CM9.0000000000003254. Epub 2024 Jul 30.

Bioinformatics tools and resources for cancer and application

Affiliations
Review

Bioinformatics tools and resources for cancer and application

Jin Huang et al. Chin Med J (Engl). .

Abstract

Tumor bioinformatics plays an important role in cancer research and precision medicine. The primary focus of traditional cancer research has been molecular and clinical studies of a number of fundamental pathways and genes. In recent years, driven by breakthroughs in high-throughput technologies, large-scale cancer omics data have accumulated rapidly. How to effectively utilize and share these data is particularly important. To address this crucial task, many computational tools and databases have been developed over the past few years. To help researchers quickly learn and understand the functions of these tools, in this review, we summarize publicly available bioinformatics tools and resources for pan-cancer multi-omics analysis, regulatory analysis of tumorigenesis, tumor treatment and prognosis, immune infiltration analysis, immune repertoire analysis, cancer driver gene and driver mutation analysis, and cancer single-cell analysis, which may further help researchers find more suitable tools for their research.

PubMed Disclaimer

Conflict of interest statement

None.

Figures

Figure 1
Figure 1
An overview of computational approaches and tools for tumor bioinformatics (by Figdraw).

References

    1. Hanahan D. Hallmarks of cancer: New dimensions. Cancer Discov 2022;12:31–46. doi: 10.1158/2159-8290.Cd-21-1059. - PubMed
    1. Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: Integrating omics and clinical data. Nat Rev Cancer 2022;22:131–142. doi: 10.1038/s41568-021-00418-1. - PubMed
    1. Liu CJ Hu FF Xie GY Miao YR Li XW Zeng Y, et al. GSCA: An integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform 2023;24:bbac558. doi: 10.1093/bib/bbac558. - PubMed
    1. Jiménez-Santos MJ, García-Martín S, Fustero-Torre C, Di Domenico T, Gómez-López G, Al-Shahrour F. Bioinformatics roadmap for therapy selection in cancer genomics. Mol Oncol 2022;16:3881–3908. doi: 10.1002/1878-0261.13286. - PMC - PubMed
    1. Cancer Genome Atlas Research Network; Weinstein JN Collisson EA Mills GB Shaw KR Ozenberger BA, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet 2013;45:1113–1120. doi: 10.1038/ng.2764. - PMC - PubMed